Skip to main content
. 2019 Nov 11;2019(11):CD008900. doi: 10.1002/14651858.CD008900.pub3

Comparison 5. Sensitivity analyses.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Change of general cognitive function measured by MMSE 1 232 Mean Difference (IV, Fixed, 95% CI) 1.48 [0.06, 2.91]
2 Change of general cognitive function measured by ADAS‐cog+ score 1 232 Mean Difference (IV, Fixed, 95% CI) ‐6.11 [‐8.16, ‐4.06]
3 Improvement of general cognitive function reported as responder rates 1 232 Risk Ratio (M‐H, Fixed, 95% CI) 1.57 [1.29, 1.91]
4 Change of executive function measured by the Trail‐Making Test 1 232 Mean Difference (IV, Fixed, 95% CI) ‐15.31 [‐30.19, ‐0.43]
5 Improvement of global function reported as responder rates 1 232 Risk Ratio (M‐H, Fixed, 95% CI) 3.07 [1.86, 5.07]
6 Non‐serious adverse events 1 232 Risk Ratio (M‐H, Fixed, 95% CI) 1.54 [0.62, 3.84]